-
1
-
-
34249674023
-
Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: Role of increase rates of gluconeogenesis
-
Bock G, Chittilapilly E, Basu R, et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increase rates of gluconeogenesis. Diabetes 2007:7:1703-11.
-
(2007)
Diabetes
, vol.7
, pp. 1703-1711
-
-
Bock, G.1
Chittilapilly, E.2
Basu, R.3
-
2
-
-
33646782893
-
Distinguishing nonalcoholic statohepatitis from fatty liver: Serum-free fatty acids, insulin resistance, and serum lipoproteins
-
Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic statohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Liver Int 2006;26:566-71.
-
(2006)
Liver Int
, vol.26
, pp. 566-571
-
-
Bookman, I.D.1
Pham, J.2
Guindi, M.3
Heathcote, E.J.4
-
3
-
-
33847316067
-
Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2
-
Kawaguchi T, Ide T, Taniguchi E, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007;102:570-6.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 570-576
-
-
Kawaguchi, T.1
Ide, T.2
Taniguchi, E.3
-
4
-
-
21544436004
-
Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study
-
Nannipieri M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 2005;28:1757-62.
-
(2005)
Diabetes Care
, vol.28
, pp. 1757-1762
-
-
Nannipieri, M.1
Gonzales, C.2
Baldi, S.3
-
5
-
-
4644337374
-
Elevations in markers of liver injury and risk of type 2 diabetes: The insulin resistance atherosclerosis study
-
Hanley AJ, Williams K, Festa A, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004;53:2623-32.
-
(2004)
Diabetes
, vol.53
, pp. 2623-2632
-
-
Hanley, A.J.1
Williams, K.2
Festa, A.3
-
6
-
-
34547931223
-
Liver enzymes as a predictor for incident diabetes in a Japanese population: The Hisayama study
-
Doi Y, Kubo M, Yonemoto K, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity 2007;15:1841-50.
-
(2007)
Obesity
, vol.15
, pp. 1841-1850
-
-
Doi, Y.1
Kubo, M.2
Yonemoto, K.3
-
7
-
-
38749102436
-
Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study
-
Monami M, Bardini G, Lamanna C, et al. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008;57:387-92.
-
(2008)
Metabolism
, vol.57
, pp. 387-392
-
-
Monami, M.1
Bardini, G.2
Lamanna, C.3
-
8
-
-
33644823983
-
Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men
-
Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005;28:2913-8.
-
(2005)
Diabetes Care
, vol.28
, pp. 2913-2918
-
-
Wannamethee, S.G.1
Shaper, A.G.2
Lennon, L.3
Whincup, P.H.4
-
9
-
-
33845544078
-
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes
-
Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006;14 Suppl 3:121S-7S.
-
(2006)
Obesity
, vol.14
, Issue.SUPPL. 3
-
-
Haffner, S.M.1
-
10
-
-
9244242904
-
Federation meeting: Screening for type 2 diabetes
-
World Health Organization, Geneva: World Health Organization;
-
World Health Organization. Report of a World Health Organization and International Diabetes Federation meeting: screening for type 2 diabetes. Geneva: World Health Organization; 2003.
-
(2003)
Report of a World Health Organization and International Diabetes
-
-
-
11
-
-
0041886596
-
Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2003;52:833-7.
-
(2003)
MMWR Morb Mortal Wkly Rep
, vol.52
, pp. 833-837
-
-
-
12
-
-
33749608155
-
Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes
-
Koopman RJ, Mainous AG III, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006;4:427-32.
-
(2006)
Ann Fam Med
, vol.4
, pp. 427-432
-
-
Koopman, R.J.1
Mainous III, A.G.2
Liszka, H.A.3
-
13
-
-
18844465939
-
A Danish diabetes risk score for targeted screening: The Inter99 study
-
Glümer C, Carstensen B, Sandbæk A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004;27:727-33.
-
(2004)
Diabetes Care
, vol.27
, pp. 727-733
-
-
Glümer, C.1
Carstensen, B.2
Sandbæk, A.3
Lauritzen, T.4
Jørgensen, T.5
Borch-Johnsen, K.6
-
14
-
-
18144425460
-
Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance
-
Franciosi M, De Berardis G, Rossi MCE, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance. Diabetes Care 2005;28:1187-94.
-
(2005)
Diabetes Care
, vol.28
, pp. 1187-1194
-
-
Franciosi, M.1
De Berardis, G.2
Rossi, M.C.E.3
-
15
-
-
33645473408
-
Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index
-
Thomas C, Hyppönen E, Power C. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 2006;166:682-8.
-
(2006)
Arch Intern Med
, vol.166
, pp. 682-688
-
-
Thomas, C.1
Hyppönen, E.2
Power, C.3
-
16
-
-
33845996154
-
Standards of medical care in diabetes, 2007
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes, 2007. Diabetes Care 2007;30:S4-S41.
-
(2007)
Diabetes Care
, vol.30
-
-
-
17
-
-
1042268060
-
Screening for type 2 diabetes
-
American Diabetes Association
-
American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004;27:S11-S14.
-
(2004)
Diabetes Care
, vol.27
-
-
-
18
-
-
56749169413
-
-
US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality; 2008 June. Publication No. 08-05116-EF-2. Available from http://www.ahrq.gov/clinic/ uspstf08/type2/type2rs.htm. Accessed 2 September 2008.
-
US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality; 2008 June. Publication No. 08-05116-EF-2. Available from http://www.ahrq.gov/clinic/ uspstf08/type2/type2rs.htm. Accessed 2 September 2008.
-
-
-
-
20
-
-
56749169411
-
-
National Health and Nutrition Examination Survey. Data Sets and Related Documentation. Available from, Accessed December 2007
-
National Center for Health Statistics, Centers for Disease Control. National Health and Nutrition Examination Survey. Data Sets and Related Documentation. Available from http://www.cdc.gov/nchs/about/major/nhanes/ datalink.htm. Accessed December 2007.
-
-
-
-
21
-
-
56749179517
-
-
Available from, Accessed 12 December 2007
-
National Institute for Alcohol Abuse and Alcoholism. Clinicians Guide 2005. Available from http://pubs.niaaa.nih.gov/publications/Practitioner/ CliniciansGuide2005/clinicians_guide.htm. Accessed 12 December 2007.
-
(2005)
Clinicians Guide
-
-
-
22
-
-
0037469232
-
AHA/CDC Scientific Statement. Markers of inflammation and cardiovascular disease
-
Pearson TA, Mensah GA, Alexander RW, et al. AHA/CDC Scientific Statement. Markers of inflammation and cardiovascular disease. Circulation 2003;107:499-511.
-
(2003)
Circulation
, vol.107
, pp. 499-511
-
-
Pearson, T.A.1
Mensah, G.A.2
Alexander, R.W.3
-
23
-
-
0002109787
-
Cognitive aspects of reporting cancer prevention examination and tests
-
Vital Health Stat, Washington DC: National Center for Health Statistics;
-
Sudman S, Warnecke R, Johnson T, O'Rourke D, Davis AM. Cognitive aspects of reporting cancer prevention examination and tests. Vital Health Stat, series 6, number 7. Washington DC: National Center for Health Statistics; 1994.
-
(1994)
series
, vol.6
, Issue.7
-
-
Sudman, S.1
Warnecke, R.2
Johnson, T.3
O'Rourke, D.4
Davis, A.M.5
|